BU Burcon NutraScience

Burcon CEO to Deliver Keynote at Plant Protein Innovation Center Workshop

Vancouver, British Columbia--(Newsfile Corp. - October 24, 2023) - Burcon NutraScience Corporation (TSX: BU) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, is pleased to announce that its CEO, Kip Underwood, has been invited to participate as a keynote speaker and panelist at this year's Process Scale Up Workshop hosted by Plant Protein Innovation Center ("PPIC") at the University of Minnesota on November 6th - 7th, 2023.

As a key figure in the plant protein industry, Mr. Underwood is honored to share his insights and expertise at this pivotal event. The keynote address by Mr. Underwood is scheduled for November 6th, during which he will provide valuable perspectives on the challenges and opportunities of scaling up next generation protein technologies, and how collaboration between companies is often the key to success.

"We are thrilled to have Mr. Underwood from Burcon NutraScience Corporation join us as a keynote speaker and panelist at the Process Scale Up Workshop," expressed Dr. Pam Ismael, PPIC Director. "With his wealth of knowledge and experience in the plant protein field, we anticipate that his contributions will help us better understand the unique dynamics of commercializing alternative proteins within the backdrop of a vibrant food ecosystem."

This two-day workshop, held at the Coffman Memorial Union - Great Hall on the University of Minnesota Minneapolis campus, will focus on the challenges and opportunities of process scale up for alternative protein ingredients and products. The workshop audience would be both smaller start-ups and established corporations in the alternative protein category.

The Plant Protein Innovation Center (PPIC) at the University of Minnesota is the first research organization in the US dedicated to bringing together interdisciplinary researchers and industry partners to deliver new, nutritious, and functional plant protein ingredients and products. Its founding members include Archer Daniels Midland Company, Cargill, Conagra, Danone, General Mills, Ingredion, Saputo, among others.

For further information regarding PPIC's Process Scale Up Workshop, please visit their website .

About Burcon NutraScience Corporation

Burcon is a global technology leader in the development of plant-based proteins for foods and beverages. Our proteins exhibit superior functionality, taste and nutrition, making them ideal ingredients for food formulators. With over two decades of experience, Burcon has amassed an extensive patent portfolio covering its specialty plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds, among other plant sources. Burcon is striving to become a vertically integrated provider of specialty plant-based protein solutions that delivers on health, nutrition and sustainability. Supporting the growing trend towards a plant-based diet, Burcon is developing premium protein ingredients that we believe are better for you and better for the planet. For more information, visit .

Forward-Looking Information Cautionary Statement

The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements or forward-looking information can be identified by words such as "anticipate," "aim", "intend," "plan," "goal," "project," "estimate," "expect," "believe," "future," "likely," "may," "should," "could," "will" and similar references to future periods. All statements included in this release, other than statements of historical fact, are forward-looking statements. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon's plans and expectations include the implementation of our business model and growth strategies; trends and competition in our industry our future business development, financial condition and results of operations and our ability to obtain financing cost-effectively; potential changes of government regulations; and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled "Risk Factors" in Burcon's annual information form for the year ended March 31, 2023 and its other public filings with Canadian securities regulators on SEDAR+ at . This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements or information. Any forward-looking statement or information speaks only as of the date on which it was made, and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and, accordingly, investors should not rely on such statements.

Industry and Investor Contact
Paul Lam
Director, Investor Relations and Communications
Burcon NutraScience Corporation
Tel (604) 733-0896, Toll-free (888) 408-7960

Media Contact:
Steve Campbell, APR
President
Campbell & Company Public Relations
Tel (604) 888-5267

To view the source version of this press release, please visit

EN
24/10/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Burcon NutraScience

 PRESS RELEASE

Burcon Integrates Protein Technologies at Galesburg Facility

Vancouver, British Columbia--(Newsfile Corp. - April 1, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, is pleased to announce that it has successfully installed and commissioned equipment for its proprietary process at the Galesburg facility."In just 10 days, our team-working alongside our valued partner RE ProMan LLC-successfully installed and commissioned our proprietary unit processes at the Galesburg facility," said Kip Underwood, Burcon's chief exec...

 PRESS RELEASE

Burcon Announces its Alliance Partner Completes Acquisition of Protein...

Vancouver, British Columbia--(Newsfile Corp. - March 10, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, proudly announces that its alliance partner, RE ProMan, LLC ("ProMan"), has successfully completed the acquisition of a protein production facility located in Galesburg, Illinois (the "Transaction")."We are thrilled to complete this Transaction ahead of schedule and begin integrating Burcon's technologies into the facility," said John Vassallo, a Burco...

 PRESS RELEASE

Burcon Announces Details of $9.43 Million Rights Offering

Vancouver, British Columbia--(Newsfile Corp. - February 18, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, is pleased to announce that, further to its press release dated February 13, 2025 with respect to the completion of Burcon's rights offering (the "Rights Offering"), Burcon has issued 110,986,126 Common shares of Burcon ("Common Shares") at a price of $0.085 per share for aggregate gross proceeds to Burcon of $9,433,821 under the Rights Offering."Wi...

 PRESS RELEASE

Burcon Reports Fiscal 2025 Third Quarter Results

Vancouver, British Columbia--(Newsfile Corp. - February 14, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, reported results for the fiscal third quarter ended December 31, 2024.“For the first time, Burcon will soon have full operational control of a facility to produce its entire portfolio of plant proteins,” said Kip Underwood, Burcon’s chief executive officer. “This marks a significant milestone for Burcon, reflecting our alliance partner’s confidence...

 PRESS RELEASE

Burcon Announces Completion of $9.43 Million Rights Offering

Vancouver, British Columbia--(Newsfile Corp. - February 13, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, is pleased to announce the completion of its rights offering (the "Rights Offering"), which expired at 5:00pm (EST) on February 12, 2025. The Rights Offering will result in the issuance of 110,986,126 Common shares of Burcon ("Common Shares") at a price of $0.085 per share for gross proceeds of approximately $9.43 million.“We are pleased to succes...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch